Carlotta Raschioni

734 total citations
11 papers, 566 citations indexed

About

Carlotta Raschioni is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Carlotta Raschioni has authored 11 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Carlotta Raschioni's work include Cancer Immunotherapy and Biomarkers (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Carlotta Raschioni is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Carlotta Raschioni collaborates with scholars based in Italy, United States and Hungary. Carlotta Raschioni's co-authors include Giulia Bottai, Libero Santarpia, Luca Di Tommaso, Massimo Roncalli, Laura Paladini, George A. Călin, Linda Fabris, Amedeo Columbano, Maria Maddalena Angioni and Silvia Giordano and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Carlotta Raschioni

11 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlotta Raschioni Italy 9 284 201 158 150 141 11 566
Yibin Ren China 12 365 1.3× 149 0.7× 163 1.0× 68 0.5× 85 0.6× 13 531
Fubo Ji China 5 196 0.7× 83 0.4× 95 0.6× 136 0.9× 76 0.5× 11 355
Michaela Bissinger Germany 11 387 1.4× 101 0.5× 172 1.1× 129 0.9× 38 0.3× 16 549
Martina Mang Leng Lei Hong Kong 8 239 0.8× 123 0.6× 133 0.8× 38 0.3× 60 0.4× 10 394
Patrick Reichl Austria 5 232 0.8× 151 0.8× 76 0.5× 48 0.3× 114 0.8× 6 405
Anja Hohmeyer Germany 3 234 0.8× 122 0.6× 79 0.5× 60 0.4× 91 0.6× 3 390
Matthias Van Haele Belgium 12 241 0.8× 106 0.5× 100 0.6× 50 0.3× 55 0.4× 15 460
Zhifa Cao China 7 191 0.7× 89 0.4× 103 0.7× 61 0.4× 76 0.5× 11 380
Hui Rao China 10 299 1.1× 103 0.5× 125 0.8× 77 0.5× 38 0.3× 19 439
Kai‐Yu Ng Hong Kong 9 402 1.4× 130 0.6× 235 1.5× 42 0.3× 46 0.3× 11 542

Countries citing papers authored by Carlotta Raschioni

Since Specialization
Citations

This map shows the geographic impact of Carlotta Raschioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlotta Raschioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlotta Raschioni more than expected).

Fields of papers citing papers by Carlotta Raschioni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlotta Raschioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlotta Raschioni. The network helps show where Carlotta Raschioni may publish in the future.

Co-authorship network of co-authors of Carlotta Raschioni

This figure shows the co-authorship network connecting the top 25 collaborators of Carlotta Raschioni. A scholar is included among the top collaborators of Carlotta Raschioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlotta Raschioni. Carlotta Raschioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Gentilini, Alessandra, Alessandra Caligiuri, Chiara Raggi, et al.. (2019). CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(9). 2246–2256. 16 indexed citations
2.
Raschioni, Carlotta, Giulia Bottai, Andrea Sagona, et al.. (2018). CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression. Disease Markers. 2018. 1–9. 13 indexed citations
3.
Bottai, Giulia, Lixia Diao, Keith Baggerly, et al.. (2017). Integrated MicroRNA–mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer. International Journal of Molecular Sciences. 18(1). 194–194. 16 indexed citations
4.
Bottai, Giulia, Carlotta Raschioni, Agnese Losurdo, et al.. (2016). An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers. Breast Cancer Research. 18(1). 121–121. 91 indexed citations
5.
Paladini, Laura, Linda Fabris, Giulia Bottai, et al.. (2016). Targeting microRNAs as key modulators of tumor immune response. Journal of Experimental & Clinical Cancer Research. 35(1). 103–103. 153 indexed citations
6.
Bottai, Giulia, Carlotta Raschioni, Agnese Losurdo, et al.. (2016). Abstract P4-04-06: Immune balance between tumor-infiltrating lymphocytes and tumor-associated macrophages impacts the outcome of triple negative breast cancer patients. Cancer Research. 76(4_Supplement). P4–4. 2 indexed citations
7.
Bottai, Giulia, Carlotta Raschioni, Borbála Székely, et al.. (2016). AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients. npj Breast Cancer. 2(1). 16033–16033. 46 indexed citations
8.
Personeni, Nicola, Lorenza Rimassa, Claudio Verusio, et al.. (2015). FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study. Clinical Colorectal Cancer. 14(3). 162–169. 9 indexed citations
9.
Sciarra, Amedeo, Maxime Ronot, Luca Di Tommaso, et al.. (2015). TRIP: a pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinoma. Liver International. 35(11). 2466–2473. 26 indexed citations
10.
Perra, Andrea, Marta Anna Kowalik, Elena Ghiso, et al.. (2014). YAP activation is an early event and a potential therapeutic target in liver cancer development. Journal of Hepatology. 61(5). 1088–1096. 190 indexed citations
11.
Personeni, Nicola, Lorenza Rimassa, Claudio Verusio, et al.. (2013). Prognostic factors in KRAS wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts) treated with biweekly cetuximab (C) plus irinotecan, fluorouracil, and leucovorin (FOLFIRI): A phase II study.. Journal of Clinical Oncology. 31(15_suppl). e14611–e14611. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026